Moscow and Kyiv echanged a number of drone strikes, with both sides partially successful in intercepting some of them. On the night of 3 January, Russian air defences reportedly destroyed 16 ...

Ukrainian forces carried out an attack on a major commercial port in Russia over the weekend, using long-range drones to target and disrupt the operations of Moscow's sanctions-evading "shadow fleet." ...

Russia is demanding the United Nations condemn Kyiv following an alleged drone attack that it claims killed a journalist working for a Russian outlet and injured several others. Russia’s ...

To complement the OCS, TMDX created the National OCS Program (NOP), a logistics service that manages organ retrieval and delivery. Therefore, unlike relying on third-party transportation ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of $90.00. The company’s shares closed last Friday at ...

TransMedics (NASDAQ:TMDX) is a medical technology company, which was founded in 1998 by Dr. Waleed Hassanein, a general surgeon who also serves as the company's CEO. It is headquartered in Andover ...

Leading organ transplant technology provider TransMedics (NASDAQ: TMDX) increased sales by more than 100% in 10 straight quarters from early 2022 to mid-2024. However, after delivering revenue ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Transmedics (NASDAQ: TMDX) fell 28.1% in December, according to data from S&P Global Market Intelligence. The stock was already down significantly from its highs heading into the month ...

Transmedics replaced its CFO in early December. Management also narrowed fourth-quarter guidance to the lower half of the previous range. Can Transmedics reaccelerate growth after this slowdown ...